The historical rank and industry rank for Cochlear's EV-to-EBIT or its related term are showing as below:
ASX:COH'
s EV-to-EBIT Range Over the Past 10 Years
Min: -56.06 Med: 32.21 Max: 54.93
Current: 42.88
During the past 13 years, the highest EV-to-EBIT of Cochlear was 54.93. The lowest was -56.06. And the median was 32.21.
ASX:COH's EV-to-EBIT is ranked worse than 79.7% of 463
companies
in the Medical Devices & Instruments industry
Industry Median: 19.93
vs ASX:COH: 42.88
The historical data trend for Cochlear's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Cochlear's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cochlear's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cochlear's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Cochlear's EV-to-EBIT falls into.
Cochlear's current Enterprise Value is A$20,494 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cochlear's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$478 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cochlear (ASX:COH) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Cochlear's Enterprise Value for the quarter that ended in Dec. 2023 was A$19,336 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cochlear's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was A$478 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cochlear EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Cochlear's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Cochlear is the leading cochlear implant device manufacturer with around 60% global market share. Developed markets contribute 80% of group revenue where cochlear implants are the standard of care for children with severe to profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2020, 49% of revenue came from the Americas, 35% from Europe, the Middle East, and Africa, and 16% from the Asia-Pacific segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASX:COH has been successfully added to your 